Dr Andrew SOKOL
USA
28 October 2023, Saturday, 1020 – 1045hr
Speaker (virtual): AAGL Session
Pelvic Organ Prolapse Management – State of the Art from an U.S. Perspective
Dr Andrew Sokol is the President of AAGL, and a board-certified Female Pelvic Medicine and Reconstructive Surgeon and Professor of OB/GYN and Urology at Georgetown University Medical School in Washington, DC. He is an internationally recognized expert in vaginal and laparoscopic pelvic floor surgery and in the treatment of pelvic floor disorders. He has previously served on the AAGL board of directors from 2012 - 2014 and has been a member of the JMIG editorial board since 2012. He was also a founding member of the urogynecology special interest group and has served as its chair. He was a member of the scientific program committee for the 42nd and 45th annual meetings and served as the program chair in 2022. He has also held numerous leadership positions in the prestigious Society of Gynecologic Surgeons as well as the American Urogynecologic Society.
Dr. Sokol graduated with Phi Beta Kappa honors from the University of Michigan and earned his medical degree with Alpha Omega Alpha honors from Wayne State University School of Medicine in Detroit in 1998. He completed his OB/GYN residency at Northwestern University in Chicago, IL in 2002. In 2005, he completed a combined fellowship in Minimally Invasive Surgery and Female Pelvic Medicine and Reconstructive Surgery at The Cleveland Clinic Foundation under the tutelage of Drs. Marie Fidela Paraiso, Tommaso Falcone, and Mark Walters.
Dr. Sokol is the Editor of a gynecology textbook entitled The Requisites in Obstetrics and Gynecology: General Gynecology (Elsevier, 2007) and has authored over 50 peer-reviewed manuscripts and book chapters. He is a winner of the Golden Laparoscope and Robotic Technology awards at the AAGL annual meeting and has won numerous awards for his teaching and research.
Dr. Sokol’s research interests include surgical management of pelvic organ prolapse and urinary incontinence, biomaterials (e.g., mesh) and pelvic reconstructive surgery. He is actively involved in clinical research trials that focus on surgical therapy for pelvic organ prolapse and stress urinary incontinence.